Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 826 AL 840

Transcranial alternating current stimulation (tACS) at gamma frequency: an up-and-coming tool to modify the progression of Alzheimer's Disease

De Paolis ML, Paoletti I, Zaccone C, Capone F, D'Amelio M, Krashia P.

Transl Neurodegener. 2024 Jun 27;13(1):33. doi: 10.1186/s40035-024-00423-y.

Alzheimer's Disease: Combination Therapies and Clinical Trials for Combination Therapy Development

Cummings JL, Osse AML, Kinney JW, Cammann D, Chen J.

CNS Drugs. 2024 Aug;38(8):613-624. doi: 10.1007/s40263-024-01103-1. Epub 2024 Jun 27.

Phytoactive drugs used in the treatment of Alzheimer's disease and dementia

Soni AG, Verma A, Joshi R, Shah K, Soni D, Kaur CD, Saraf S, Chauhan NS.

Naunyn Schmiedebergs Arch Pharmacol. 2024 Nov;397(11):8633-8649. doi: 10.1007/s00210-024-03243-z. Epub 2024 Jun 28.

BACE1 Inhibitors for Alzheimer's Disease: Current Challenges and Future Perspectives

Coimbra JRM, Resende R, Custódio JBA, Salvador JAR, Santos AE.

J Alzheimers Dis. 2024;101(s1):S53-S78. doi: 10.3233/JAD-240146.

Beyond Amyloid-β: Reevaluating Its Physiological Role to Find Safe Therapies Against Alzheimer's Disease

Puzzo D.

J Alzheimers Dis. 2024;100(3):783-786. doi: 10.3233/JAD-240406.

Effects of ketogenic diet on cognitive function of patients with Alzheimer's disease: a systematic review and meta-analysis

Rong L, Peng Y, Shen Q, Chen K, Fang B, Li W.

J Nutr Health Aging. 2024 Aug;28(8):100306. doi: 10.1016/j.jnha.2024.100306. Epub 2024 Jun 28.

[Prospects for use of short peptides in pharmacotherapeutic correction of Alzheimer's disease.]

Ilina AR, Popovich IG, Ryzhak GA, Khavinson VK.

Adv Gerontol. 2024;37(1-2):10-20.

Anti-amyloid-β Antibodies and Anti-tau Therapies for Alzheimer's Disease: Recent Advances and Perspectives

Suzuki N, Hatta T, Ito M, Kusakabe KI.

Chem Pharm Bull (Tokyo). 2024;72(7):602-609. doi: 10.1248/cpb.c24-00069.

Neuroimmune Dysfunction in Alzheimer's Disease and Other Forms of Dementia

Yamane T, Yoshioka T, Shimo Y.

Chem Pharm Bull (Tokyo). 2024;72(7):618-629. doi: 10.1248/cpb.c23-00464.

Epigenetic Inhibitors as Alzheimer's Disease Therapeutic Agents

Yamashita Y, Itoh Y, Takada Y, Suzuki T.

Chem Pharm Bull (Tokyo). 2024;72(7):630-637. doi: 10.1248/cpb.c23-00027.

GSK3: A potential target and pending issues for treatment of Alzheimer's disease

Zhao J, Wei M, Guo M, Wang M, Niu H, Xu T, Zhou Y.

CNS Neurosci Ther. 2024 Jul;30(7):e14818. doi: 10.1111/cns.14818.

Natural Bioactive Compounds from Macroalgae and Microalgae for the Treatment of Alzheimer's Disease: A Review

Lee JY, Wong CY, Koh RY, Lim CL, Kok YY, Chye SM.

Yale J Biol Med. 2024 Jun 28;97(2):205-224. doi: 10.59249/JNKB9714. eCollection 2024 Jun.

APP dyshomeostasis in the pathogenesis of Alzheimer's disease: implications for current drug targets

Sirisi S, Sánchez-Aced É, Belbin O, Lleó A.

Alzheimers Res Ther. 2024 Jun 29;16(1):144. doi: 10.1186/s13195-024-01504-w.

Neolignans in Magnolia officinalis as natural anti-Alzheimer's disease agents: A systematic review

Li N, Liang Y, Zhang L, Xu C, Wang L.

Ageing Res Rev. 2024 Aug;99:102398. doi: 10.1016/j.arr.2024.102398. Epub 2024 Jun 30.

Evidence mapping and quality assessment of systematic reviews on exercise intervention for Alzheimer's disease

Xu Z, Tang J, Yi W.

Complement Ther Med. 2024 Sep;84:103065. doi: 10.1016/j.ctim.2024.103065. Epub 2024 Jun 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias